← Back to Clinical Trials
Recruiting NCT06013046

NCT06013046 Wheelchair User Physical Activity Training Intervention to Enhance Cardiometabolic Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06013046
Status Recruiting
Phase
Sponsor Washington University School of Medicine
Condition Physical Disability
Study Type INTERVENTIONAL
Enrollment 108 participants
Start Date 2023-08-10
Primary Completion 2027-10-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Intensity-controlled physical activity training (IPAT)Education and Access (EA)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 108 participants in total. It began in 2023-08-10 with a primary completion date of 2027-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of the study is to improve cardiometabolic health outcomes for wheelchair users and identify strategies for achieving sufficient physical activity intensity during bouts of structured physical activity.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Has a physical disability requiring the use of a wheelchair (includes manual wheelchairs, motorized wheelchairs, motor-assisted wheelchairs, and electric scooters) * Ability to attend weekly exercise sessions in person * Ability to independently move one or both upper extremities * Has participated in no more than 60 minutes of moderate-intensity physical activity per week in the past month * English-speaking * Able to provide informed consent * Ability to complete a valid V02max score with 2 attempts Exclusion Criteria: * Determination by their physician to be medically unstable * Has had cardiovascular complications within the past year or unstable heart disease * Currently receiving medical treatment for an acute injury * Presence of a stage IV pressure injury * Currently pregnant or suspect pregnancy

Contact & Investigator

Central Contact

Kimberly A Walker, OTD

✉ walker.k@wustl.edu

📞 314-273-7010

Principal Investigator

Kerri A Morgan, PhD

PRINCIPAL INVESTIGATOR

Washington University School of Medicine

Frequently Asked Questions

Who can join the NCT06013046 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Physical Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06013046 currently recruiting?

Yes, NCT06013046 is actively recruiting participants. Contact the research team at walker.k@wustl.edu for enrollment information.

Where is the NCT06013046 trial being conducted?

This trial is being conducted at St Louis, United States.

Who is sponsoring the NCT06013046 clinical trial?

NCT06013046 is sponsored by Washington University School of Medicine. The principal investigator is Kerri A Morgan, PhD at Washington University School of Medicine. The trial plans to enroll 108 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology